Indications
Therapeutic Asset Ratings
6,308 results matching 1 filter
91,564
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Lisaftoclax
Myeloid Neoplasm
Ascentage Pharma Group Inc.
P1/2
CC
(47)
LMP744
IDH-Wildtype Glioblastoma
National Institute of Neurological Disorders and Stroke (NINDS)
P1/2
CC
(47)
lnp1265
Hemophilia B
Regeneron Pharmaceuticals
P1/2
CC
(47)
Lorlatinib
Metastatic Neoplasm
Memorial Sloan Kettering Cancer Center
P1/2
CC
(47)
Low Dose Lx2006
Friedreich Ataxia
Lexeo Therapeutics
P1/2
CC
(47)
lpm6690176
Colorectal Cancer
Luye Pharma Group Ltd.
P1/2
CC
(47)
ly3884961
Gaucher Disease
Prevail Therapeutics
P1/2
CC
(47)
ly3884963
Frontotemporal Dementia
Prevail Therapeutics
P1/2
CC
(47)
mb-106
B-Cell Non-Hodgkin Lymphoma
Mustang Bio
P1/2
CC
(47)
Mdna11
Lynch Syndrome
Medicenna Therapeutics, Inc.
P1/2
CC
(47)
Mdna11
Malignant Pleural Mesothelioma
Medicenna Therapeutics, Inc.
P1/2
CC
(47)
mdx2001
Hepatocellular Carcinoma
ModeX Therapeutics, An OPKO Health Company
P1/2
CC
(47)
Mesenchymal Stem Cells Derived Exosomes
Malignant Pancreatic Neoplasm
M.D. Anderson Cancer Center
P1/2
CC
(47)
Mesna
Lymphoblastic Lymphoma
M.D. Anderson Cancer Center
P1/2
CC
(47)
mhb048c for
Castration-Resistant Prostate Carcinoma
Minghui Pharmaceutical (Hangzhou) Ltd
P1/2
CC
(47)
Mitoxantrone
Hemophagocytic Syndrome
Beijing Tongren Hospital
P1/2
CC
(47)
mk-4830
Renal Cell Carcinoma
Merck Sharp & Dohme LLC
P1/2
CC
(47)
mk-5684
Castration-Resistant Prostate Carcinoma
Merck Sharp & Dohme LLC
P1/2
CC
(47)
Modi-1 Moditope
Ovarian Serous Adenocarcinoma
Scancell Ltd
P1/2
CC
(47)
Modi-1 Moditope
Renal Cell Carcinoma
Scancell Ltd
P1/2
CC
(47)
Monoclonal Antibody Neo-201
Uterine Cancer
Precision Biologics, Inc
P1/2
CC
(47)
Montanide Isa 51
Non-Small Cell Squamous Lung Carcinoma
Roswell Park Cancer Institute
P1/2
CC
(47)
Mosunetuzumab
B-Cell Neoplasm
BeOne Medicines
P1/2
CC
(47)
Mrna-3210
Phenylketonuria
ModernaTX, Inc.
P1/2
CC
(47)
Mrt-2359
Diffuse Large B-Cell Lymphoma
Monte Rosa Therapeutics, Inc
P1/2
CC
(47)
Showing 2476 to 2500 of 6,308 assets
Previous
Page 100 of 253
Next